Transformando el futuro de la industria farmacéutica
Email: info@amarintech.com.ar
Far away, in 1979, the first transdermal patch to reach the market, produced under an industrial controlled process and backed by clinical studies, was launched in US under the brand name TransderScop®. [...]
The Latin American surveillance health authorities have made progress year after year with respect to the requirements of product registration in general, seeking the best balance between the safety of its inhabitants, the efficacy of the products and the economic reality of each country. [...]
Transdermal drug delivery systems, also named as “patches”, are controlled release dosage forms designed to deliver a therapeutically effective amount of drug through the skin during the time of application of the product, which may vary between 9 h (methylphenidate) to 148 h (buprenorphine). [...]